Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India Pharma and Healthcare Fund · Direct ✕Edelweiss Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseInvescoEdelweiss
NAV₹10.7800₹9.5446
NAV date20 Nov 202620 Nov 2026
History2 months2.3 years
Expense ratio1.9%1.2%
StarsNot ratedNot rated
Growth Score——

Returns

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
1 month+19.78%+5.85%
3 months—+1.17%
6 months—+5.73%
YTD—+3.05%
1 year—+3.75%
3 years (CAGR)——
5 years (CAGR)——
10 years (CAGR)——
Since launch+7.58%−2.21%

Risk

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
Volatility——
Downside volatility——
Sharpe——
Sortino——
Calmar——
Return / risk——
Deepest fall−11.39%−26.39%
Days to recover14—
Below its high+0.00%−7.61%

Against benchmark

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
Best 1-year—+20.97%
Middle 1-year—+1.01%
Worst 1-year—−14.64%
1-year periods with a loss—43.9%
Middle 3-year——
Positive months——
Best day+3.62%+4.77%
Worst day−2.74%−3.85%
Worst 5% day−1.53%−2.02%
Positive days48.9%54.0%
NAVs a year48247

SIP of ₹10,000 a month

Invesco India Pharma and Healthcare FundEdelweiss Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR——
1-year XIRR—+9.07%

Holdings overlap i

Overlap compares the shares two funds hold, so it needs at least two of these funds with shares in a loaded monthly filing.
  • Invesco India Pharma and Healthcare Fund: no monthly portfolio filing from Invesco is loaded yet, so it is left out here.
  • Edelweiss Business Cycle Fund: no monthly portfolio filing from Edelweiss is loaded yet, so it is left out here.

Search Growth